Curcumin: Does It Actually Work?
Last reviewed: 2026-02-20 00:00:00 +0000 UTC
Meta-analysis verifiedSnakeOilCheck earns commissions from qualifying purchases made through affiliate links on this site. Our editorial content and meta-analyses are produced independently and are not influenced by affiliate relationships.
What Is Curcumin?
Curcumin is the active compound in turmeric. It’s what gives the spice its yellow color. Turmeric has been used in traditional medicine for centuries, but the science on curcumin has only gotten serious in the last 15 years.
Here’s the catch that most supplement companies won’t tell you. Plain curcumin has terrible bioavailability. Your body can’t absorb it. If you’re taking a basic turmeric capsule, almost none of it reaches your bloodstream.
You need an enhanced formulation. Longvida, Meriva, CurcuWIN, or plain curcumin with piperine (black pepper extract). Without one of these, you’re wasting your money.
We analyzed 66 RCTs from multiple meta-analyses covering inflammation, joint pain, and depression. Here’s what the evidence actually shows.
The Evidence, Claim by Claim
The sections below break down each major claim with real numbers from published meta-analyses. Every effect size, confidence interval, and study count comes from peer-reviewed research.
Inflammation: Strong Evidence
This is curcumin’s strongest area. Dehzad et al. (2023) pooled 66 RCTs and found significant reductions in three major inflammation markers. CRP dropped by 0.58 mg/L. TNF-alpha dropped by 3.48 pg/mL. IL-6 dropped by 1.31 pg/mL. Only IL-1beta didn’t change.
An umbrella review by Naghsh et al. (2023) looked at 10 meta-analyses covering 85 RCTs with 5,870 total participants. They rated the CRP evidence as “moderate certainty” under GRADE.
The heterogeneity is very high (I2 = 98.9% for CRP). That means the size of the effect varies a lot between studies. But the direction is consistent. Curcumin lowers inflammation. How much depends on the dose, the formulation, and who’s taking it.
Joint Pain: Strong Evidence, Comparable to NSAIDs
This is where curcumin really shines. Zeng et al. (2021) pooled 15 RCTs with 1,621 people with osteoarthritis.
The VAS pain reduction was 11.55 points on a 100-point scale (p < 0.00001). The heterogeneity was I2 = 0%. That’s almost unheard of for a supplement trial. Every single study agreed.
WOMAC pain scores showed a medium-to-large effect (SMD = -0.66). Function improved too (SMD = -0.79).
The best part? Head-to-head trials against ibuprofen and diclofenac found no significant difference. Curcumin works as well as standard painkillers. And it caused 45% fewer adverse events (RR = 0.55).
If you have osteoarthritis and can’t tolerate NSAIDs, curcumin is a legitimate option.
Depression: Promising but Weak
Wang et al. (2021) pooled 10 RCTs with 594 people. The overall effect was small (SMD = -0.32). In people with diagnosed depression, it was slightly better (SMD = -0.35, I2 = 7%).
People taking curcumin were 3.2 times more likely to have a clinical response than placebo. That sounds impressive, but the confidence interval is wide (1.28 to 7.99) and only 594 people were studied.
The evidence quality is rated LOW. Don’t swap your antidepressant for turmeric. But as an add-on? It’s worth discussing with your doctor.
The Bioavailability Problem
This matters more for curcumin than almost any other supplement. Plain curcumin has roughly 1% oral bioavailability. That means 99% of what you swallow never reaches your blood.
Here’s what actually works:
- Longvida gives about 65x better absorption. It wraps curcumin in a lipid matrix.
- Meriva (phytosome technology) gives about 29x better absorption.
- CurcuWIN uses a hydrophilic carrier for about 46x improvement.
- Piperine (black pepper extract) gives about 20x better absorption by blocking liver metabolism.
If your curcumin bottle doesn’t mention one of these technologies, it’s probably not doing much.
Who Should NOT Take Curcumin
Don’t take curcumin if you’re on blood thinners. It inhibits platelet aggregation, which increases bleeding risk. This includes warfarin, aspirin, and clopidogrel.
Avoid it if you have gallbladder disease or gallstones. Curcumin stimulates bile production, which can cause painful flare-ups.
Don’t use it during pregnancy or breastfeeding. There isn’t enough safety data at supplement doses.
Stop taking it at least 2 weeks before surgery due to blood-thinning effects.
If you have diabetes, monitor your blood sugar closely. Curcumin can lower it, and combining it with diabetes medication may drop it too far.
The Bottom Line
Curcumin is one of the most studied natural anti-inflammatories. The evidence for reducing inflammation markers is strong, backed by 66 RCTs and an umbrella review. For osteoarthritis, it’s genuinely comparable to NSAIDs with fewer side effects.
The depression evidence is real but weak. Small studies, small effects. Worth trying as an add-on, not as a replacement.
But none of this matters if you buy the wrong product. Plain turmeric capsules are a waste of money. Get an enhanced formulation like Longvida, Meriva, or at minimum curcumin with piperine. The form you take matters more than the dose on the label.
The Evidence, Claim by Claim
Reduces inflammation markers ✓ Works
66 trials show curcumin lowers CRP, TNF-alpha, and IL-6. These are the three big inflammation markers your doctor tests for. An umbrella review of 10 meta-analyses with nearly 6,000 people confirmed the effect. IL-1beta didn't budge, though.
Very high heterogeneity (I2 = 98.9% for CRP) means the size of the effect varies a lot between studies. The direction is consistent. It works, but how much depends on the dose, formulation, and the population studied.
View full statistical analysis
Relieves joint pain ✓ Works
15 trials with over 1,600 people found curcumin reduces joint pain about as well as ibuprofen or diclofenac. The VAS pain data has I2 = 0%, meaning every study agrees. And curcumin caused 45% fewer side effects than NSAIDs.
This is unusually clean data for a supplement. Zero heterogeneity on VAS pain is rare. Head-to-head NSAID trials are the gold standard here. This genuinely works for osteoarthritis.
View full statistical analysis
Improves depression symptoms ? Maybe
10 trials with about 600 people show a small but real improvement in depression scores. People taking curcumin were 3.2 times more likely to have a clinical response. But the effect size is small, the studies are small, and the evidence quality is low.
Low heterogeneity (I2 = 15%) is a good sign. But only 594 total participants across 10 studies. Evidence quality rated LOW. Don't replace your antidepressant with turmeric. Could be a helpful add-on, but more research is needed.
View full statistical analysis
Lowers blood sugar and improves glycemic control ✓ Works
104 trials show curcumin lowers fasting blood sugar and HbA1c in people with type 2 diabetes and metabolic syndrome. The evidence is rated GRADE HIGH for fasting blood sugar. HbA1c drops about 0.3-0.5%, which is clinically meaningful. The effect on insulin resistance is inconsistent across studies.
High heterogeneity (I2 = 88% for FBS in T2DM) means the size of the effect varies a lot between studies. But the direction is extremely consistent. 14 of 15 meta-analyses agree that curcumin lowers blood sugar. Best effects with enhanced formulations at 500-1500 mg/day.
View full statistical analysis
Improves cholesterol and lipid profiles ✓ Works
104 trials show curcumin raises HDL (good cholesterol), lowers triglycerides, and lowers LDL (bad cholesterol). The evidence is rated GRADE HIGH for HDL. Total cholesterol doesn't change much. The effects are stronger in people with diabetes or metabolic syndrome.
HDL improvement is the most consistent finding (GRADE HIGH). LDL and triglyceride reductions are real but less certain (GRADE LOW to MODERATE). Total cholesterol doesn't move. These are modest lipid effects, not a replacement for statins.
View full statistical analysis
Reduces anxiety symptoms ? Maybe
7 trials with 494 people show a small but real reduction in anxiety symptoms. The effect is small (SMD -0.22) but consistent, with zero heterogeneity. All studies agree on the direction. But no one has tested curcumin specifically for diagnosed anxiety disorders. The evidence comes from people with other chronic diseases.
Zero heterogeneity (I2 = 0%) is a good sign. But only 494 participants across 7 studies, and all in chronic disease populations. The WFSBP/CANMAT guidelines say there's insufficient evidence for curcumin in diagnosed anxiety disorders. This is a secondary benefit, not a primary treatment.
View full statistical analysis
Publication Bias Assessment
| Egger's Test | z = —, p = 0.506 | no significant asymmetry detected |
|---|
Subgroup Analysis
| Subgroup | Studies (k) | Effect (g) |
|---|
| Subgroup | Studies (k) | Effect (g) |
|---|
Supports weight loss and reduces BMI ? Maybe
60 trials with 3,691 people show curcumin causes a small weight loss of about 0.8 kg. BMI drops about 0.3 points and waist circumference shrinks about 1.3 cm. The effect is real but modest. You won't notice it on the scale. It's rated GRADE HIGH for weight, but the actual amount lost is tiny.
High heterogeneity across studies. The effect is statistically significant but clinically modest. Curcumin ranks 7th out of 18 nutraceuticals for weight loss. Larger effects in T2DM (-1.9 kg) and with phytosomal formulations. Don't take curcumin for weight loss. But if you're taking it for inflammation or blood sugar, the small weight benefit is a bonus.
View full statistical analysis
Protects liver health and improves fatty liver disease ? Maybe
15 trials with 905 NAFLD patients show curcumin lowers ALT by about 4 U/L and AST by about 3 U/L. These are the two main liver enzymes your doctor checks. The effect is statistically significant but modest. ALP didn't budge. Four supporting meta-analyses all agree that curcumin helps liver enzymes in fatty liver disease.
Very high heterogeneity (I2 > 90%) and almost all studies are from Iran. Formulations ranged wildly from 80 mg nanocurcumin to 3000 mg turmeric powder. Several studies from the same research groups may overlap. Important FDA safety context: turmeric is the most common herbal cause of liver injury in the US, so more isn't necessarily better.
View full statistical analysis
Reduces blood pressure ? Maybe
15 trials with 855 people with prediabetes or type 2 diabetes show curcumin lowers systolic blood pressure by about 2.7 mmHg. That's a small but real drop. Diastolic blood pressure didn't change significantly. All studies were in diabetic populations, so we don't know if this works for people with normal blood sugar.
SBP evidence is GRADE MODERATE but DBP is GRADE VERY LOW. The 2.7 mmHg SBP drop is clinically modest. For comparison, the DASH diet reduces SBP by about 11 mmHg. Don't take curcumin as a blood pressure treatment. But if you're taking it for diabetes or inflammation, the small BP bonus is nice.
View full statistical analysis
Improves ulcerative colitis symptoms ? Maybe
11 trials show curcumin roughly doubles the odds of remission in ulcerative colitis when added to standard medication. Patients were 2.45 times more likely to achieve clinical remission and 2.11 times more likely to achieve endoscopic healing. Side effects were no different from placebo. But this does NOT work for Crohn's disease.
High heterogeneity (I2 = 88% for remission) is a big concern. Results varied a lot between studies. Three UC studies aren't even indexed in PubMed. Formulations ranged from 50 mg SMEDDS to 10 g whole turmeric. One combination product (curcumin + QingDai) can't be attributed to curcumin alone. Curcumin is always adjunctive here, never standalone.
View full statistical analysis
Reduces exercise-induced muscle soreness ? Maybe
Two meta-analyses disagree on this one. Beba et al. (2022) pooled 10 trials and found curcumin reduces soreness, muscle damage (CK), and inflammation after exercise. But Oxley & Peart (2023) analyzed 16 studies by time point and found nothing statistically significant. Both see trends favoring curcumin. The studies are tiny (10-30 people each) and use wildly different formulations and doses.
Grade C because the two meta-analyses reach opposite conclusions. Every study is small. Doses ranged from 150 mg Theracurmin to 5000 mg standard curcumin. Exercise protocols ranged from eccentric arm curls to downhill running to cycling. Several studies were funded by curcumin manufacturers. Don't expect miracles for gym recovery.
View full statistical analysis
Dosage Guide
| Dose Range in Studies | 500-1500mg |
|---|---|
| Most-Studied Dose | 1000mg |
| Best Form | Enhanced formulation (Longvida, Meriva, CurcuWIN, or with piperine) |
| Timing | With food, split into 2 doses |
| Time to Effect | 2-4 weeks for inflammation, 4-8 weeks for joint pain |
| Cycling | Not required, safe for daily long-term use |
| Notes | Plain turmeric capsules don't work. Curcumin has terrible bioavailability on its own. You need an enhanced formulation. Longvida gives ~65x better absorption. Meriva (phytosome) gives ~29x. Adding piperine (black pepper extract) gives ~20x. Without one of these, you're wasting your money. |
Ask Your Doctor Before Taking If You Have
- Gallbladder disease or gallstones (stimulates bile production)
- Bleeding disorders (may thin blood)
- Pregnancy and breastfeeding (insufficient safety data)
- Surgery (stop 2 weeks before due to blood-thinning effects)
- Iron deficiency (high doses may reduce iron absorption)
Drug Interactions
| Medication | Risk | Why |
|---|---|---|
| Blood thinners (warfarin, aspirin, clopidogrel) | high | Curcumin inhibits platelet aggregation, increasing bleeding risk |
| Diabetes medications | moderate | May lower blood sugar, additive effect with diabetes drugs |
| Chemotherapy agents | moderate | May interfere with certain chemo drugs, consult oncologist |
Possible Side Effects
- Mild GI upset or nausea at high doses
- Diarrhea with very high doses (>2000mg)
- Yellow staining of teeth if held in mouth
Products That Match the Research
Disclosure: Links below are affiliate links. We earn a commission if you buy. We only link to products that match the doses and forms used in the published research.
Nootropics Depot Longvida Curcumin
Longvida formula, 65x better absorption, third-party tested, 400mg per cap
What to Avoid
Plain turmeric powder has near-zero curcumin absorption without enhancement
Frequently Asked Questions
Does curcumin actually reduce inflammation?
Yes. 66 randomized controlled trials show it lowers CRP, TNF-alpha, and IL-6. An umbrella review of 10 meta-analyses with nearly 6,000 people confirmed the effect at moderate certainty. You need an enhanced formulation for absorption, though.
Is curcumin as effective as ibuprofen for joint pain?
The data says yes. 15 trials with 1,621 people found no significant difference between curcumin and NSAIDs like ibuprofen or diclofenac. Curcumin also caused 45% fewer side effects. It takes longer to kick in, but it works.
Why doesn't regular turmeric work?
Curcumin has terrible bioavailability. Your body barely absorbs it. Plain turmeric capsules don't deliver meaningful blood levels. You need an enhanced form like Longvida (65x absorption), Meriva (29x), or curcumin with piperine from black pepper (20x).
Can curcumin help with depression?
Maybe. 10 trials with 594 people show a small improvement in depression scores. People taking curcumin were 3.2 times more likely to respond. But the studies are small and the evidence quality is low. Don't replace medication with it.
Is curcumin safe to take with blood thinners?
No, not without talking to your doctor first. Curcumin inhibits platelet aggregation, which means it thins your blood. Combining it with warfarin, aspirin, or other blood thinners can increase bleeding risk. Also avoid it if you have gallbladder problems.
Want to see the data? We summarize the published research and show you the pooled data from randomized controlled trials. Read our full methodology and dataset below
Summary
Based on our systematic summary of 11 health claims across 418 studies with 29,345 total participants, 4 claims have strong evidence supporting them, 7 claims show promising but incomplete evidence. Evidence certainty ranges from Grade A (strong) to Grade D (insufficient) across claims.
Summary of Findings
| Outcome | Studies | Participants | Effect Size (95% CI) | Certainty |
|---|---|---|---|---|
| Reduces inflammation markers | 66 | 5,870 | WMD -0.58 (-0.74 to -0.41) | Grade A |
| Relieves joint pain | 15 | 1,621 | WMD -11.55 (-14.3 to -9.06) | Grade A |
| Improves depression symptoms | 10 | 594 | SMD -0.32 (-0.5 to -0.13) | Grade B |
| Lowers blood sugar and improves glycemic control | 104 | 7,216 | SMD -0.54 (-0.72 to -0.36) | Grade A |
| Improves cholesterol and lipid profiles | 104 | 7,216 | SMD 0.45 (0.25 to 0.65) | Grade A |
| Reduces anxiety symptoms | 7 | 494 | SMD -0.22 (-0.4 to -0.05) | Grade B |
| Supports weight loss and reduces BMI | 60 | 3,691 | WMD -0.82 (-1.3 to -0.35) | Grade B |
| Protects liver health and improves fatty liver disease | 15 | 905 | WMD -4.1 (-7.16 to -1.04) | Grade B |
| Reduces blood pressure | 15 | 855 | WMD -2.69 (-3.84 to -1.55) | Grade B |
| Improves ulcerative colitis symptoms | 11 | 602 | RR 2.45 (1.09 to 5.51) | Grade B |
| Reduces exercise-induced muscle soreness | 11 | 281 | WMD -0.56 (-0.84 to -0.27) | Grade C |
Review Protocol
For each claim, we searched for the most recent published systematic review or meta-analysis of randomized controlled trials evaluating curcumin supplementation in human participants compared to placebo or no treatment.
When a full protocol file is available, it can be found at /supplements/curcumin/protocol/.
Search Strategy
Databases searched: PubMed, Cochrane, Google Scholar
Last searched: 2026-02-19T10:00:00Z
Studies reviewed: 91
Studies meeting inclusion criteria: 66
Searches targeted published systematic reviews and meta-analyses of RCTs for each health claim. Individual RCTs were included when no pooled analysis existed.
Study Selection
Each claim was evaluated independently. The PRISMA flow below summarizes the selection process per outcome.
| Claim | Identified | Screened | Excluded | Included |
|---|---|---|---|---|
| Reduces anxiety symptoms | 1649 | 1003 | 15 |
Risk of Bias
Assessment tool: Cochrane RoB 2 for RCTs, ROBINS-I for non-randomized studies.
Individual study risk-of-bias assessments are summarized below by claim. Full per-domain assessments will be available in the downloadable study ledger when published.
| Claim | Studies | Low RoB | Some Concerns | High RoB |
|---|---|---|---|---|
| Reduces inflammation markers | 66 | 0 | 0 | 0 |
| Relieves joint pain | 15 | 3 | 0 | 0 |
| Improves depression symptoms | 10 | 3 | 1 | 0 |
| Lowers blood sugar and improves glycemic control | 104 | 0 | 5 | 0 |
| Improves cholesterol and lipid profiles | 104 | 1 | 4 | 0 |
| Reduces anxiety symptoms | 7 | 2 | 5 | 0 |
| Supports weight loss and reduces BMI | 60 | 2 | 4 | 0 |
| Protects liver health and improves fatty liver disease | 15 | 3 | 12 | 0 |
| Reduces blood pressure | 15 | 13 | 0 | 3 |
| Improves ulcerative colitis symptoms | 11 | 3 | 5 | 3 |
| Reduces exercise-induced muscle soreness | 11 | 6 | 5 | 0 |
Results
Reduces inflammation markers
Pooled effect: WMD = -0.58 (95% CI: -0.74 to -0.41, p = 0.001)
Heterogeneity: I² = 98.9%, τ² =
66 trials show curcumin lowers CRP, TNF-alpha, and IL-6. These are the three big inflammation markers your doctor tests for. An umbrella review of 10 meta-analyses with nearly 6,000 people confirmed the effect. IL-1beta didn't budge, though.
Relieves joint pain
Pooled effect: WMD = -11.55 (95% CI: -14.3 to -9.06, p = 1e-05)
Heterogeneity: I² = 0%, τ² =
15 trials with over 1,600 people found curcumin reduces joint pain about as well as ibuprofen or diclofenac. The VAS pain data has I2 = 0%, meaning every study agrees. And curcumin caused 45% fewer side effects than NSAIDs.
Improves depression symptoms
Pooled effect: SMD = -0.32 (95% CI: -0.5 to -0.13, p = 0.001)
Heterogeneity: I² = 15%, τ² =
10 trials with about 600 people show a small but real improvement in depression scores. People taking curcumin were 3.2 times more likely to have a clinical response. But the effect size is small, the studies are small, and the evidence quality is low.
Lowers blood sugar and improves glycemic control
Pooled effect: SMD = -0.54 (95% CI: -0.72 to -0.36, p = 0.001)
Heterogeneity: I² = 88%, τ² =
104 trials show curcumin lowers fasting blood sugar and HbA1c in people with type 2 diabetes and metabolic syndrome. The evidence is rated GRADE HIGH for fasting blood sugar. HbA1c drops about 0.3-0.5%, which is clinically meaningful. The effect on insulin resistance is inconsistent across studies.
Improves cholesterol and lipid profiles
Pooled effect: SMD = 0.45 (95% CI: 0.25 to 0.65, p = 0.001)
Heterogeneity: I² = moderate-to-high%, τ² =
104 trials show curcumin raises HDL (good cholesterol), lowers triglycerides, and lowers LDL (bad cholesterol). The evidence is rated GRADE HIGH for HDL. Total cholesterol doesn't change much. The effects are stronger in people with diabetes or metabolic syndrome.
Reduces anxiety symptoms
Pooled effect: SMD = -0.22 (95% CI: -0.4 to -0.05, p = 0.01)
Heterogeneity: I² = 0%, τ² =
7 trials with 494 people show a small but real reduction in anxiety symptoms. The effect is small (SMD -0.22) but consistent, with zero heterogeneity. All studies agree on the direction. But no one has tested curcumin specifically for diagnosed anxiety disorders. The evidence comes from people with other chronic diseases.
Supports weight loss and reduces BMI
Pooled effect: WMD = -0.82 (95% CI: -1.3 to -0.35, p = 0.001)
Heterogeneity: I² = high%, τ² =
60 trials with 3,691 people show curcumin causes a small weight loss of about 0.8 kg. BMI drops about 0.3 points and waist circumference shrinks about 1.3 cm. The effect is real but modest. You won't notice it on the scale. It's rated GRADE HIGH for weight, but the actual amount lost is tiny.
Protects liver health and improves fatty liver disease
Pooled effect: WMD = -4.1 (95% CI: -7.16 to -1.04, p = 0.009)
Heterogeneity: I² = high (>90%)%, τ² =
15 trials with 905 NAFLD patients show curcumin lowers ALT by about 4 U/L and AST by about 3 U/L. These are the two main liver enzymes your doctor checks. The effect is statistically significant but modest. ALP didn't budge. Four supporting meta-analyses all agree that curcumin helps liver enzymes in fatty liver disease.
Reduces blood pressure
Pooled effect: WMD = -2.69 (95% CI: -3.84 to -1.55, p = 0.001)
Heterogeneity: I² = 30.1%, τ² =
15 trials with 855 people with prediabetes or type 2 diabetes show curcumin lowers systolic blood pressure by about 2.7 mmHg. That's a small but real drop. Diastolic blood pressure didn't change significantly. All studies were in diabetic populations, so we don't know if this works for people with normal blood sugar.
Improves ulcerative colitis symptoms
Pooled effect: RR = 2.45 (95% CI: 1.09 to 5.51, p = 0.03)
Heterogeneity: I² = 88%, τ² =
11 trials show curcumin roughly doubles the odds of remission in ulcerative colitis when added to standard medication. Patients were 2.45 times more likely to achieve clinical remission and 2.11 times more likely to achieve endoscopic healing. Side effects were no different from placebo. But this does NOT work for Crohn's disease.
Reduces exercise-induced muscle soreness
Pooled effect: WMD = -0.56 (95% CI: -0.84 to -0.27, p = 0.001)
Heterogeneity: I² = low-to-moderate%, τ² =
Two meta-analyses disagree on this one. Beba et al. (2022) pooled 10 trials and found curcumin reduces soreness, muscle damage (CK), and inflammation after exercise. But Oxley & Peart (2023) analyzed 16 studies by time point and found nothing statistically significant. Both see trends favoring curcumin. The studies are tiny (10-30 people each) and use wildly different formulations and doses.
Publication Bias
Funnel plots and Egger's regression test were used to assess publication bias where 10 or more studies were available.
| Claim | Egger's p | Interpretation | Trim-and-Fill Estimate |
|---|---|---|---|
| Reduces anxiety symptoms | 0.506 | no significant asymmetry detected | — |
Certainty of Evidence
Evidence grades follow a simplified GRADE framework: A (high certainty), B (moderate), C (low), D (very low/insufficient).
| Outcome | Grade | Verdict | Key Limitation |
|---|---|---|---|
| Reduces inflammation markers | A | works | Very high heterogeneity (I2 = 98.9% for CRP) means the size of the effect varies a lot between studies. The direction is … |
| Relieves joint pain | A | works | This is unusually clean data for a supplement. Zero heterogeneity on VAS pain is rare. Head-to-head NSAID trials are the … |
| Improves depression symptoms | B | maybe | Low heterogeneity (I2 = 15%) is a good sign. But only 594 total participants across 10 studies. Evidence quality rated … |
| Lowers blood sugar and improves glycemic control | A | works | High heterogeneity (I2 = 88% for FBS in T2DM) means the size of the effect varies a lot between studies. But the … |
| Improves cholesterol and lipid profiles | A | works | HDL improvement is the most consistent finding (GRADE HIGH). LDL and triglyceride reductions are real but less certain … |
| Reduces anxiety symptoms | B | maybe | Zero heterogeneity (I2 = 0%) is a good sign. But only 494 participants across 7 studies, and all in chronic disease … |
| Supports weight loss and reduces BMI | B | maybe | High heterogeneity across studies. The effect is statistically significant but clinically modest. Curcumin ranks 7th out … |
| Protects liver health and improves fatty liver disease | B | maybe | Very high heterogeneity (I2 > 90%) and almost all studies are from Iran. Formulations ranged wildly from 80 mg … |
| Reduces blood pressure | B | maybe | SBP evidence is GRADE MODERATE but DBP is GRADE VERY LOW. The 2.7 mmHg SBP drop is clinically modest. For comparison, … |
| Improves ulcerative colitis symptoms | B | maybe | High heterogeneity (I2 = 88% for remission) is a big concern. Results varied a lot between studies. Three UC studies … |
| Reduces exercise-induced muscle soreness | C | maybe | Grade C because the two meta-analyses reach opposite conclusions. Every study is small. Doses ranged from 150 mg … |
Limitations
- Searches were limited to English-language publications. Non-English studies may be missing.
- Study identification and data extraction were assisted by AI tools. All extracted data has been manually verified against source publications.
- Small-study effects may inflate some pooled estimates, particularly for outcomes with fewer than 10 included trials.
- Supplement formulations, dosages, and populations varied across studies. Subgroup analyses were limited by the number of available studies per subgroup.
- Most included studies relied on published meta-analyses as the primary data source. Individual participant data was not available.
Conflicts of Interest & Disclosures
SnakeOilCheck earns commissions from qualifying purchases made through affiliate links on this site. Our meta-analyses are produced independently and are not influenced by affiliate relationships.
All claims are sourced from PubMed-indexed meta-analyses and RCTs. Every assertion includes a specific citation with PMID for independent verification.
AI-assisted research disclosure: Study identification and data extraction were assisted by AI tools. All extracted data has been manually verified against source publications.
Raw Data
Downloadable study ledger files (CSV, JSON) and verification logs will be published as we complete the transition to our new data format. In the meantime, all source meta-analyses are cited in the claim sections above with DOIs for independent verification.
License: CC BY 4.0
How to Cite
SnakeOilCheck. Curcumin: Systematic Review and Meta-Analysis. snakeoilcheck.com/supplements/curcumin/. Updated 2026-02-20 00:00:00 +0000 UTC.